• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Corona Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71174.0
  • ISIN : INE02ZQ01018
2,271.60 101 (4.63%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    2,167.90

  • Today’s High

    2,294.00

  • Open

    2,171.10

  • Perv Close

    2,171.10

  • 52W Low

    1,336.60

  • 52W High

    2,294.00

Key Indicators

  • P/E(TTM)

    63.30

  • Mar.Cap (₹Cr.)

    13,893.13

  • Div & Yield %

    0.44

  • Book Value(₹)

    131.47

  • Debt-Equity Ratio

    4.63

  • AGM Date

    03-Nov-2026

  • EPS

    35.93

  • P/E Ratio

    63.30

Financials Ratios

  • Debt-Equity Ratio

    0.21

  • Mar.Cap (₹Cr.)

    13,893.13

  • RONW (%)

    20.36

  • ROCE (%)

    23.46

Score Board

  • Equity (₹ in Cr.)

    61.16

  • BV (₹)

    131.50

  • Sales( ₹ in Cr.)

    1,403.18

  • NP (in Cr.)

    199.58

  • NP Var(%)

    33.0

  • Div%

    100.0

  • CPS (₹)

    38.80

  • EPS (₹)

    32.60

  • Traded Value (₹ in Lakhs)

    13,280.61

  • 52 Week High

    2,294.00

  • 52 Week Low

    1,336.60

  • Price BSE

    2171.0

  • Price NSE

    2,171.00

  • Market Capital( in Cr.)

    13,280.61

  • P/C Ratio

    55.90

  • P/E Ratio

    66.50

  • Price Vs.BV

    32.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,403.18 1,196.42 1,014.47 884.05 617.33 576.16
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,403.18 1,196.42 1,014.47 884.05 617.33 576.16
Other Income 10.65 5.93 6.46 7.05 6.60 4.94
Stock Adjustments -7.05 23.74 0.78 14.51 40.57 2.72
Total Income 1,406.78 1,226.09 1,021.71 905.61 664.50 583.82
EXPENDITURE :            
Raw Materials 253.89 260.26 227.61 225.46 187.21 147.19
Power and Fuel Cost 5.69 6.03 5.66 3.97 3.51 1.14
Employee Cost 403.02 346.14 295.37 254.77 226.65 176.36
Other Manufacturing Expenses 11.00 6.57 6.46 4.64 7.24 1.54
Selling and Administration Expenses 355.83 301.37 259.84 233.11 92.46 130.99
Miscellaneous Expenses 92.36 59.81 65.58 48.63 123.00 16.29
Employee Benefit Expenses 403.02 346.14 295.37 254.77 226.65 176.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,121.79 980.18 860.52 770.58 640.08 473.49
Operating Profit 284.99 245.91 161.20 135.03 24.42 110.33
Interest 6.97 10.60 14.44 4.27 4.73 2.01
Gross Profit 278.02 235.31 146.76 130.76 19.69 108.32
Depreciation 37.87 37.16 28.28 20.10 20.48 15.89
Profit Before Tax 240.15 198.15 118.48 110.66 -0.79 92.43
Current Tax 51.48 44.80 18.88 26.27 0.00 25.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.82 4.30 9.10 -0.32 -0.39 -3.50
Reported Net Profit 184.85 149.05 90.50 84.70 -0.40 69.95
Extraordinary Items -14.73 -0.53 -0.71 0.11 0.18 0.00
Adjusted Net Profit 199.58 149.58 91.21 84.59 -0.58 69.95
Adjustment below Net Profit 0.11 -0.87 -1.67 -0.45 0.00 -0.17
P & L Balance brought forward 502.98 377.43 305.55 228.27 236.00 166.22
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 44.71 22.63 16.94 6.97 7.33 0.00
P & L Balance carried down 643.23 502.98 377.43 305.55 228.27 236.00
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 73.10 37.00 27.70 0.00 0.00
Dividend Per Share(Rs) 10.00 7.31 3.70 2.77 0.00 0.00
Earnings Per Share-Unit Curr 30.22 24.37 14.80 13.85 -0.08 150.71
Earnings Per Share(Adj)-Unit Curr 30.22 - - - - -
Book Value 121.97 99.04 78.51 66.70 62.86 727.91
Book Value(Adj)-Unit Curr 121.97 - - - - -

Shareholding Pattern

  • Promoter Group

    69.00%

  • Public Share Holding

    31.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 42,197,968 69.00 42,197,968 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 42,197,968 69.00 42,197,968 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,574,451 4.21 2,574,451 43
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 155,675 0.25 155,675 2
Mutual Funds / UTI 9,825,070 16.06 9,825,070 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 81,528 0.13 81,528 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 12,636,724 20.66 12,636,724 65
2] Non Institution
Bodies Corporate 274,764 0.45 274,764 58
Clearing Members 5,759 0.01 5,759 5
Directors of their Relatives 57 0.00 57 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 10,689 0.02 10,689 157
Foreign Non Institution Other 5,270,310 8.62 5,270,310 1
Hindu Undivided Families 21,720 0.04 21,720 530
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 630,174 1.03 630,174 20,265
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 109,759 0.18 109,759 1
Others 128 0.00 128 2
Sub Total 6,325,396 10.34 6,325,396 21,027
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 61,160,088 100.00 61,160,088 21,098

Company Background

Corona Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Corona Remedies Ltd
  • BSE Code : 71174.0
  • ISIN : INE02ZQ01018

  • Incorporation Year

    2004

  • Registered Office

    Corona House C-Mondeal Busines
    #NAME?, Ahmedabad,
    Gujarat-380059

  • Telephone

    +91 79 4023 3000

  • FAX

  • Chairman

    KIRTIKUMAR LAXMIDAS MEHTA

  • Managing Director

    NIRAVKUMAR KIRTIKUMAR MEHTA

  • Company Secretary

    Chetna Darajiya

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Corona Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Corona Remedies 2,274.30 1,413.83 1,403.18 67.33 28.95
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77